InvestorsHub Logo
Followers 14
Posts 3822
Boards Moderated 1
Alias Born 07/07/2002

Re: linhdtu post# 11890

Wednesday, 05/28/2014 11:36:01 AM

Wednesday, May 28, 2014 11:36:01 AM

Post# of 20689
Does Momenta still (ever?) have a technical edge? It seems the more I dig, the more competition I find. Even if they have an edge, it is not preventing others from coming up with biosimilars that get FDA clearance. Lovenox is first example. Same thing with Copaxone. If not, then the big prize would have to be from proprietary molecules.